Bristol-Myers Squibb
BMY
#188
Rank
NZ$188.71 B
Marketcap
NZ$92.70
Share price
1.53%
Change (1 day)
-11.80%
Change (1 year)

P/S ratio for Bristol-Myers Squibb (BMY)

P/S ratio as of February 2026 (TTM): 2.37

According to Bristol-Myers Squibb's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.12. At the end of 2025 the company had a P/S ratio of 1.87.

P/S ratio history for Bristol-Myers Squibb from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20251.87-22.81%
20242.424.41%
20232.32-30%
20223.3111.08%
20212.98-9.5%
20203.30-39.73%
20195.4746.19%
20183.74-22.49%
20174.83-3.97%
20165.03-27.14%
20156.9012.28%
20146.1515.44%
20135.3276.57%
20123.017.25%
20112.8121.74%
20102.31-10.66%
20092.5815.66%
20082.23-21.96%
20072.86-0.67%
20062.8823.12%
20052.34-17.55%
20042.847.6%
20032.645.74%
20022.50-52.16%
20015.22

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.03 154.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.14 117.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.41 1.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
6.69 182.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
15.8 565.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
5.16 117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2.42 1.99%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
2.61 10.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.41 86.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
10.1 324.28%๐Ÿ‡ฌ๐Ÿ‡ง UK